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Background: Acquired brain injury (ABI) is the leading cause of disability worldwide yet there is little information
regarding the most effective way to organise ABI health care services. The aim of this review was to identify the
most up-to-date high quality evidence to answer specific questions regarding the organisation of health care
services for people with an ABI.
Methods: We conducted a systematic review of English papers using MEDLINE, EMBASE, PsycINFO, CINAHL and the
Cochrane Library. We included the most recently published high quality systematic reviews and any randomised
controlled trials, non-randomised controlled trials, controlled before after studies or interrupted time series studies
published subsequent to the systematic review. We searched for papers that evaluated pre-defined organisational
interventions for adults with an ABI. Organisational interventions of interest included fee-for-service care, integrated
care, integrated care pathways, continuity of care, consumer engagement in governance and quality monitoring
interventions. Data extraction and appraisal of included reviews and studies was completed independently by
two reviewers.
Results: A total of five systematic reviews and 21 studies were included in the review; eight of the papers (31%)
included people with a traumatic brain injury (TBI) or ABI and the remaining papers (69%) included only participants
with a diagnosis of stroke. We found evidence supporting the use of integrated care to improve functional outcome
and reduce length of stay and evidence supporting early supported discharge teams for reducing morbidity and
mortality and reducing length of stay for stroke survivors. There was little evidence to support case management or
the use of integrated care pathways for people with ABI. We found evidence that a quality monitoring intervention
can lead to improvements in process outcomes in acute and rehabilitation settings. We were unable to find any
studies meeting our inclusion criteria regarding fee-for-service care or engaging consumers in the governance of the
health care organisation.
Conclusions: The review found evidence to support integrated care, early supported discharge and quality monitoring
interventions however, this evidence was based on studies conducted with people following stroke and may not be
appropriate for all people with an ABI.
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Acquired brain injury is the most common cause of dis-
ability worldwide [1-3]. The term ABI encompasses a
number of different conditions including traumatic brain
injury, hypoxic brain injury, stroke and brain tumour [4].
These conditions may cause a complex combination of
symptoms that require treatment from multiple health
professionals. The effects of an ABI may be long-lasting
and result in the need for long-term management [5]. The
incidence of ABI, frequency of limitations in functional
ability that results from ABI, and costs associated with long
term care mean that it is important that policy makers and
health care organisations use the most effective and effi-
cient methods to organise patient care.
Currently, the organisation of health care services for
ABI varies across healthcare settings and countries and
there is a lack of synthesised information regarding ef-
fective organisational interventions. Structuring services
for people with an ABI is complex due to differences in
case presentation, occupational goals and medical and
functional needs. Differences between ABI aetiologies
also lead to variation; the effects of stroke on the brain
are much more focal in nature whereas TBI tends to
lead to more generalised damage [6]. The needs of pa-
tients with ABI are often diverse [5], for example pa-
tients with stroke are more likely to be older, retired and
may have made previous adjustments to their lifestyle
due to ageing, whereas patients with traumatic brain in-
jury tend to be of working age and are more likely to
have family and work commitments. That said, the num-
ber of elderly people with TBI is on the rise and these
patients tend to have worse medical outcomes than eld-
erly stroke patients [7]. Despite differences in character-
istics and treatment goals, people with an ABI from all
diagnoses are often treated in the same care settings and
by the same health care team and indeed, current re-
search suggests that care on a mixed neurological re-
habilitation unit is not inferior to care in a diagnostic-
specific rehabilitation unit [8]. Understanding the research
underpinning care provision across ABI is important be-
cause optimising care coordination can maximise rehabili-
tation potential, therefore optimising independence and
quality of life.
One such source of evidence available to guide clinical
care is the Evidence Based Review of Moderate to Severe
Acquired Brain Injury (ABIEBR) (www.abiebr.com) [9].
The ABIEBR is a continually updated review of evidence
based interventions for persons with ABI. The ABIEBR
includes several recommendations related to the organ-
isation of care including: that care should be provided by
dedicated multidisciplinary teams; with adherence to
acute care guidelines, that rehabilitation should be pro-
vided early and at high intensity; and patients should
have access to long term support and specialist programs(such as vocational rehabilitation). These recommenda-
tions were based on studies identified in their search;
many of these were of low quality and thus the authors
conclude that there is currently “insufficient evidence to
draw any conclusions regarding the ideal structure of a
complete model of ABI care” (p55). The definition of ABI
used in the ABIEBR does not include stroke and thus,
the large amount of research related to stroke is not con-
sidered in their summaries to date. The objective of this
review was to identify the most up-to-date, high quality
sources of evidence to answer specific questions of inter-
est regarding organising health services for people with
an acquired brain injury, inclusive of stroke.
Methods
This systematic review was undertaken to inform the de-
velopment of a new brain injury rehabilitation unit. The
research team were therefore interested in organisational
interventions, that is, interventions that relate to the
structure or delivery of health services. The research team
identified seventeen relevant systematic review questions
from the Cochrane Effective Practice and Organisation of
Care (EPOC) Group taxonomy of interventions. The
questions were presented to key stakeholders in the brain
injury rehabilitation unit and the key stakeholders voted
for the questions that were perceived to be of highest pri-
ority. Key stakeholders included ABI clinicians, healthcare
administrators and researchers. Six research questions
related to the organisation of health care services were
addressed within this systematic review (see list of Research
questions). A protocol for the review was developed and
registered with PROSPERO prior to undertaking the search
[10]. As the review involved the synthesis of already pub-
lished research, ethics approval was not required.
Inclusion criteria
Types of studies
The first step in the search was to identify high quality
published systematic reviews for each question. System-
atic reviews were not excluded on the basis of the types
of primary studies included. Where there were more
than one systematic review we included the most recent
high quality review (as assessed using the AMSTAR
checklist). We also included primary studies that were
published subsequently to systematic reviews to ensure
that we included the most recent evidence (see PRISMA
flow diagram). Studies were considered if they were ran-
domised controlled trials (RCTs), non-randomised con-
trolled trials (NRCTs), controlled before after studies
(CBAs) or interrupted time series studies (ITSs). Where
we were unable to identify any systematic reviews to ad-
dress a research question we summarised studies of the
aforementioned designs. Studies published prior to 1980
were not included; the cut-off date was chosen in order
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ceedings were not included. Details of SRs and studies
omitted from this review and the reasons for omission
are presented in an Additional file 1 (see file).
Types of participants
Participants in included reviews and studies were
aged ≥ 16 years with an acquired brain injury (as a
result of trauma, lack of oxygen to the brain, stroke,
tumours, infection, poisoning or substance abuse) [4]
utilising acute care or rehabilitation services.
Types of interventions
We included interventions that evaluated: (1) fee-for-
service versus no fee-for-service or partial fee-for-service,
(2) formal integration of services versus non-integrated
care. Integrated care was defined as care provided by the
same multidisciplinary team (this may have involved any
configuration of medical, nursing or allied health) in com-
parison to care provided by two or more teams of any
configuration. The multidisciplinary team providing the
seamless care must have had the same direct management
however may not have involved the same personnel)
(3) care based on integrated care pathways versus usual
care. An integrated care pathway (ICP) defines the ex-
pected course of events in the care of patients with a
particular condition within a set time frame; ICPs are
documented and staff are expected to adhere to the ICP.
In order to be considered in this review, the pathway
needed to be multidisciplinary (direct expected care be-
haviours in two or more professional groups). (4) a pro-
gram of continuity of care versus no follow up, usual care
or a lower quality model of continuity of care (eg fewer
contacts involved). Studies examining the effect of follow
up or case management within the same organisation or
referral to one or more other organisations were in-
cluded. The follow up was for any health care service
(rehabilitation, counselling, or medication review) and
was arranged following discharge from acute care or re-
habilitation services. Case management was defined as
the coordination of multidisciplinary care and reconciling
this with patient needs. To be classified as case manage-
ment, services needed to involve three or more of the fol-
lowing processes: entry screening, assessment, planning,
coordination, monitoring and review, exit/closure plan-
ning, (5) consumer participation in governance versus no
consumer participation or an alternative model of con-
sumer participation, and (6) presence of quality monitor-
ing systems versus no quality monitoring system or an
alternative system.
Types of outcome measures
The primary outcome measure was patient outcome.
This included outcomes measured at the level of activityor participation, health related quality of life, or mortality.
The secondary outcomes were resource use, quality of care
outcomes (such as adherence to recommended care) and
participant satisfaction. Reviews or studies were not ex-
cluded based on the outcomes assessed.
The research questions addressed within the review
are presented below:
Research questions
1. Does the presence of a ‘fee-for-service’, paid either by
the individual or insurer, improve outcomes for
patients with ABI or the organisation in comparison
to those where the individual or insurer does not
pay ‘fee-for-service’?
2. Does an integrated care model where acute and
rehabilitation, or admitted and community/
ambulatory services are provided under one
management team improve outcomes for patients
with ABI or the organisation compared with care
provided by separate management teams?
3. Does the use of an integrated care pathway (ICP)
result in improved outcomes for the patient or the
organisation compared to care which does not
routinely adhere to an ICP?
4. Does enhancing the continuity of care by providing
or organising follow up or case management
improve outcomes for patients with ABI or the
organisation in comparison to care where these
services are not provided?
5. Does engaging consumers in governance of the
health care organisation improve outcomes for
patients with ABI or the organisation in comparison
to models where there is no consumer participation
in governance?
6. Does the presence or organisation of quality
monitoring systems improve outcomes for patients
with ABI or the organisation compared with those
lacking quality monitoring systems?
Searches undertaken
The following electronic databases were searched for eli-
gible reviews and studies: Medline (Ovid) 1980-Week 4
January 2013; PsycINFO (Ovid) 1980-Week 4 January
2013; EMBASE (Ovid) 1980-Week 4 January 2013 and
CINAHL (Ebsco) 1980-21st February 2013. The search
strategy was developed (by KL in consultation with
all authors) for use in Ovid and adapted for CINAHL
(see Additional file 2 MEDLINE search strategy). The
Cochrane Library (Cochrane Database of Systematic
Reviews, Database of Abstracts of Reviews and Effects and
the Cochrane Central Register of Controlled Trials) was
searched on the 26th of January 2013 using the MESH
terms ‘stroke’ and craniocerebral trauma’. The Cochrane
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February 2013.
Data collection and analysis
One author (KL) reviewed all titles and abstracts elicited
in the search to determine whether they met the inclusion
criteria. Papers identified as being potentially relevant were
obtained in full text and reviewed independently by two
people (KL and LP). Disagreements were resolved by dis-
cussion or moderation by a third author (NL). Reasons for
the exclusion of studies obtained in full text were recorded.
The following data was extracted by one author (KL) and
checked for accuracy by a second person (LP): review or
study authors, date of publication, setting, study design,
participant eligibility criteria, number of participants, in-
tervention details, comparator details, type and timing of
outcome measures, results and the authors’ conclusion.
Studies were assessed independently by two people
(KL and LP or DW) using the AMSTAR checklist [11] for
systematic reviews, PEDro scale [12] for RCTs or Downs
and Blacks Scale [13] for all other study designs.
The details of the included papers were summarised
by research question and study type and presented in ta-
bles. No additional quantitative synthesis was conducted.
Levels of evidence were described using the classification
system used within the ABIEBR [9] which was based on
the levels of evidence used by the United Stated Agency
for Health Care Policy and Research Guidelines for
Stroke Rehabilitation. Within this classification system,
evidence is described as Level I if the findings are
supported by the results of one or more RCTs of at least
good quality (PEDro ≥ 6) and Level II if the findings
are supported by a single RCT of at least “fair quality”
(RCT <6 PEDro), NRCTs and Cohort studies.
Results
The search resulted in 11,880 citations of which 11,301
were excluded because the abstract revealed the study
did not meet the inclusion criteria. Full text articles were
obtained for the remaining 579 citations. A further 519
studies were excluded because they did not meet the in-
clusion criteria. We identified a total of 15 SRs, 43 RCTs
and two NRCTs that addressed the study design, types
of participants and intervention relevant to this review.
We then reviewed the papers to identify the most recent,
high quality systematic reviews and subsequently pub-
lished studies; we included a total of five SRs, 20 RCTs
and one NRCT in this final review. (Refer to Figure 1
PRISMA flow diagram).
We were unable to identify any SRs or studies meeting
our inclusion criteria that addressed the research ques-
tions relating to fee-for-service or consumer involvement.
Results for the remaining research questions are sum-
marised below.Integrated care
Description of reviews and studies
We were unable to identify any SRs that examined the
effectiveness of integrated care (where acute and re-
habilitation, or admitted and community/ambulatory
services were provided under one management team)
compared to care provided by different management teams
for people with an ABI. Three RCTs [14-16] were iden-
tified as meeting the inclusion criteria for this research
question (See Table 1). No NRCT, CBA or ITS studies were
identified which addressed this research question.
One RCT conducted in Norway (n = 320) compared a
‘chain of care’ provided by one team from the acute
stroke unit to the community with a more fragmented
care approach [14]. The ‘chain’ started in the acute
stroke unit, involved facilitation of discharge and coord-
ination of additional rehabilitation and follow up in the
community. The second trial (n = 81) also compared in-
tegrated care from the acute stroke unit to the home
with usual care which involved at least two different
health care teams [15]. The team providing the care
were associated with the stroke unit and provided out-
reach rehabilitation in the home. Finally, a three-armed
trial compared comprehensive stroke unit care which
comprised acute care and rehabilitation to acute care
provided by a mobile stroke team on general wards to
care provided by a domiciliary stroke team [16]. There
were several differences between the interventions pro-
vided in each of the study arms within this trial and the
level of integration of care was one of several elements
that varied. Consistent across all of the included studies
(n = 3), was that they all recruited stroke survivors who
predominantly had a moderate level of disability.
Quality of reviews and studies
The three included RCTs were all conducted in Europe
and assessed as being of good quality (PEDro score ≥6/10)
with large sample sizes (n = 81 to n = 320).
Effects of interventions
Patient outcomes Two of the RCTs reported on mortality;
of these, one of the trials found that there were reduced
odds of mortality in the integrated care group at three, six
and 12 months (OR 0.37; 95%CI 0.21 to 0.66 at 12 months)
[16] whereas the other RCT found that there were similar
levels of mortality between groups [14]. All three included
RCTs reported on participants’ level of dependence in activ-
ities of daily living following intervention [15-17]. While one
of the RCTs found no significant differences between groups
[15], the others both reported more favourable outcomes for
the integrated care group; Indredavik and colleagues (2000)
reported that a higher proportion of participants were inde-
pendent six months after stroke as measured using the Ran-
kin Scale (65% vs 52%, odds ratio (OR) = 1.72; 95% CI 1.10
Figure 1 PRISMA flow diagram.
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more participants in the integrated care group had a
favourable outcome on the Barthel Index (scores 15–20 out
of 20) than those receiving care from the mobile stroke team
at three (OR 1.16; 95% CI 1.02 to 1.32) and 12 months (OR
1.27; 95% CI 1.12 to 1.44) [16]. Two of the RCTs reported
on the impact on health related quality of life. One of the
RCTs found no significant differences between groups [15]
whereas the other RCT found that participants in the inter-
vention group reported significantly improved quality of life
(mean score 78.9 vs 75.2) [14].
Secondary outcomes All three RCTs reported on length
of stay with variability in the findings. One RCT found that
the total duration of hospital stay was similar betweengroups [16] while the remaining studies both reported a
positive effect of the intervention on length of hospital stay.
One RCT found that there was a 52% reduction in length of
hospital stay for the integrated care group (mean of 14 days
vs 29 days) [15] and the other found that the combined
stroke unit plus rehabilitation unit length of stay was statisti-
cally shorter in the integrated care group (mean of 19 days
vs 31 days) [14]. Finally, one of the RCTs assessed participant
satisfaction and found that the group receiving integrated
care reported statistically significant higher satisfaction with
active participation in treatment program planning [15].
In summary, there is Level I evidence from three RCTs
that the provision of integrated care may result in simi-
lar or reduced levels of mortality and similar or im-
proved functional outcome when compared with a more
Table 1 Integrated care
Study Patient Intervention/Comparator Outcomes Results
Indredavik 2000 Patients with
acute stroke
I: Chain of care provided by a mobile
stroke team from the acute setting
into the community
ADL function and independence,
living situation, death, LOS
Patients receiving integrated care had
improved functional outcome at
6 months (65% of the intervention
group vs 52% of the control group
were independent) and 1 year (56%
of the intervention group vs 45% of
the control group were independent).
Length of stay and levels of mortality
on the acute stroke unit were similar.
Design: RCT
Size: N = 320
Setting: Hospital
to home
Norway C: Acute care and community care
provided by different intervention
teamsPEDro: 6/10
Kalra 2000 Patients with
acute stroke
I: Comprehensive stroke ward (acute
and rehabilitation care provided)
Mortality, ADL function, living
situation, length of stay and
resource use
There was a statistically significant
reduction in mortality in the
comprehensive care group in
comparison to the group receiving
general ward care (OR 0.39 (95% CI
0.20 to 0.76 at 6 months).
Design: RCT
Size: N = 457
Setting: Hospital I: Domiciliary multidisciplinary
stroke team
United Kingdom
PEDro: 8/10 C: General ward with care from hospital
based mobile stroke team
Widen Holmqvist
1998
Patients with
acute stroke
I: Care provided by a hospital outreach
team from the acute setting into the
community
Resource use, caregivers QOL
and time spent caring, patient
satisfaction, Sickness Impact
Profile, ADL function and
independence
There were no statistically significant
differences in outcome between
groups at 3 or 12 months. Patients in
the control group spent significantly
more days in inpatient services
(mean of 29 days vs mean of 14 days)
Design: RCT
Size: N = 81
Setting: Hospital
to home
C: Acute care, rehabilitation and/or
community care provided by
different teams
Sweden
PEDro: 7/10
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used between the acute and home rehabilitation setting
may result in a significantly reduced length of stay in acute
services.
Care pathways
Description of reviews and studies
We identified a Cochrane Review published in 2004 [17]
and a RCT published in 2011 [18] that assessed the effects
of integrated care pathways (ICPs) in stroke care (See
Table 2). No NRCT, CBA or ITS studies were identified
which addressed this research question. The Cochrane
Review conducted by Kwan and colleagues included ten
studies (three RCTs, seven NRCTs) with a total of 2013
participants. Care pathways were defined as a plan of care
that “involved two or more of the following aspects of care:
assessment, investigation, diagnosis, or treatment and in-
volved two or more disciplines” [17]. The care provided for
the control group was poorly described in all studies al-
though appeared to be usual care and studies took place in
both acute care and rehabilitation units. The included RCT
conducted by Middleton and colleagues used a cluster
design to evaluate the use of an ICP designed to manage
fever, hyperglycaemia and swallowing on an acute stroke
unit [18]. The trialists randomised 19 Australian acute
stroke units and obtained data for 1696 participants.Quality of reviews and studies
The Cochrane Review was of high quality meeting 7 of
the 11 AMSTAR criteria however the authors reported
that care needed to be taken in interpretation of the re-
sults as there were issues with the methodology and
reporting of included studies.
The RCT conducted by Middleton and colleagues was
of high quality (PEDro score = 9/10).
Effects of interventions
Patient outcomes The SR and RCT both reported
mortality rates post-intervention. The SR was unable
to find any effects on mortality associated with use of
an ICP. In contrast, the RCT found that patients re-
ceiving the intervention were significantly less likely to
be dead or dependent at 90 days than patients receiv-
ing usual care (42% vs 58%, difference in absolute
change = 15.7% (95% CI 5.8 to 25.4)). The SR and
RCT both examined effects on quality of life; the SR
identified evidence (based on one RCT [19]) that
self-reported quality of life was significantly lower in
the ICP group at six months whereas the RCT found that
patients in the ICP group were more likely to have higher
scores on the physical health component of the quality of
life assessment tool (difference in absolute change = 3.4
(95% CI 1.2 to 5.5)) [19].
Table 2 Care pathways
Study Patient Intervention/Comparator Outcomes Results
Kwan 2004 Patients with
acute stroke
I: Integrated care pathway Death or dependency, complications,
readmission, use of investigations,
patient satisfaction, LOS, cost of
hospitalisation, QOL
There do not appear to be benefits in
the implementation of an ICP and it is
possible that use is associated with
reduced patient satisfaction and QOL
Design: SR C: No integrated care pathway
Size: 10 studies
Setting: Acute
AMSTAR: 7/11
Middleton 2011 Patients with
stroke
I: Integrated care pathway
directed at fever, hyperglycaemia
and swallowing
Death or dependency, ADL function,
QOL, LOS, processes of care
Patients managed using the ICP were
less likely to be dead or dependent at
90 days (42% in the intervention group
vs 58% in the control group, number
needed to treat 6.4)Design: Cluster RCT C: No integrated care pathway
Size: N = 735
Setting: Acute
Australia
PEDro: 9/10
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on resource use; the SR reported that readmissions to
hospital were lower in the ICP group (based on one
RCT and one NRCT (OR 0.11, 95% CI 0.03 to 0.39). The
data from the SR related to length of stay was conflicting
with two RCTs [19,20] finding increased length of stay
and two NRCTs [21,22] finding shorter length of stay in
the ICP group. The RCT conducted by Middleton and
colleagues found no significant differences in length of
hospital stay between groups [19]. The SR examined the
effects of ICP use on patient satisfaction and found some
evidence (based on one randomised study [20] that pa-
tient satisfaction (as rated on a scale of one to ten) was
significantly lower in participants receiving care based
on an ICP (Weighted Mean Difference (WMD) -1.1,
95% CI −1.91 to −0.29).
Based on the available evidence from one SR, there is
currently a lack of evidence supporting the implementa-
tion of ICPs to improve patient outcomes for people
with ABI and limited evidence that ICPs may reduce pa-
tient satisfaction and quality of life compared to usual
care. However, there is conflicting Level I evidence from
one high quality RCT that a specific pathway used on an
acute stroke unit to manage fever, hyperglycaemia and
swallowing can improve patient outcome of death or
dependency at 90 days compared with usual care [18].
Continuity of care
A large number of reviews and studies were identified
which addressed this research question. The purpose
and content of intervention approaches varied and to
assist in interpretation we categorised these into three
main approaches: ‘continuity of care - case management’,
‘continuity of care - early supported discharge’ and
‘continuity of care - short term program based on
consultation’. The ‘short term program’ category involvedinterventions that were short (one to three sessions),
delivered by a health professional and focussed on as-
sessment and subsequent referral to other agencies. In
all categories interventions were conducted either face-
to-face, via telephone calls or using a combination of
these methods. Details of the individual studies are pre-
sented in Table 3 and findings are summarised by inter-
vention category.
Continuity of care - case management
Description of reviews and studies In the category of
case management we included two SRs due to differ-
ences in the participants involved; one involved only
people with stroke and the other involved only people
with TBI. A Cochrane review published by Ellis and
colleagues in 2010 included 16 RCTs that examined the
effectiveness of stroke liaison workers for patients fol-
lowing stroke [23]. We found one RCT (n = 380) pub-
lished after the search date of the SR that examined the
effects of a six month case management intervention for
people with stroke on discharge from acute care[24]. In
addition, a systematic review published in 1999 exam-
ined the effectiveness of case management for patients
following traumatic brain injury [25]. Since then, three
RCTs involving people with a TBI have assessed the evi-
dence for a case management intervention [26-28]. An-
other RCT examined the evidence for case management
focussed on returning people with an ABI to work [29].
The participant group comprised seven people with
TBI, six people with cerebral infarcts, seven people
with intracranial haemorrhage and two people with other
diagnoses.
Quality of reviews and studies
The SR involving people with stroke was recently pub-
lished, involved a large number of RCTs (n = 16) and
Table 3 Continuity of care
Study Patient Intervention/Comparator Outcomes Results
Case management
Ellis 2010 Patients
with stroke
I: Stroke liason worker Subjective health, function,
participation, death,
institutionalisation, mood,
stroke related knowledge,
health service utilisation,
patient satisfaction
Patients with mild to moderate
disability had a significant
reduction in dependence
(OR 0.62, 95% CI 0.44 to 0.87)
and there were reports of higher
patient and carer satisfaction
however there was no other
evidence that the intervention
improves outcome.
Design: SR C: Alternative care or no
post-discharge care
Size: 16 studies
Setting: Predominantly
community
AMSTAR: 8/11
Chesnut 1999 Patients
with TBI
I: Long term care coordination General functional status There was a lack of high quality
studies and studies included in
the review reported conflicting
results therefore the authors
were unable to make clear
recommendations on the
evidence for this approach.
Design: SR
Size: 3 studies
Setting:
Community
AMSTAR: 3/11
Allen 2009 Patients with
stroke
I: 6 months of follow up
contact from an Advanced
Practice nurse who worked
with the GP to implement a
care plan, organised further
services and provided education
NIHSS, TUG, physical
performance test, mortality,
institutionalisation, QOL,
mgt of post-stroke
complications, stroke
knowledge and lifestyle
modification
There was little difference
between groups at 6 months.
The intervention group had
slightly improved lifestyle
management and stroke
knowledge.
Design: RCT
Size: N = 380
Setting: Acute to community
United States
PEDro: 8/10 C: Usual care plus provision of
written stroke related education.
Bell 2005 Patients
with TBI
I: Regular phone calls over
9 months upon discharge to
follow-up any issues, identify
concerns and provide
information, mentoring, goal
setting, reassurance and referral
to community resources.
Function, community
integration, neurobehavioural
functioning inventory,
Glasgow outcome scale,
QOL, emotional state
The intervention group had
significantly better scores on
functional status and perceived
quality of wellbeing than the
control group however the
magnitude of the effect is
unclear as the outcome was a
composite measure.
Design: RCT
Size: N = 171
Setting: Rehabilitation
to community
United States
PEDro: 8/10 C: Usual care
Bell 2008 Patients with
mild TBI
I: Regular phone calls over
3 months post injury after
presentation to the ED, a
contact phone number and
additional information about
brain injury and where to
get help
Head injury symptoms,
QOL. PHQ, role performance,
community participation
Patients in the intervention
group reported fewer symptoms
6 months post injury than the
control group (6.6 difference in
adjusted mean symptom score,
95% CI 2.2 to 5.2)
Design: RCT
Size: N = 366
Setting: ED to community
United States
PEDro: 8/10 C: Usual care (patient handout
and outpatient treatment if
prescribed).
Bell 2011 Patients
with TBI
I: Regular phone calls for up to
21 months post injury from a
case manager. The purpose of
the calls was to help participants
to identify, prioritise and solve
problems as independently as
possible
Function, level of disability,
participation, symptoms,
QOL, vocational status
No significant differences were
found between groups for any
of the measures at either 1 or
2 years post injury.
Design: RCT
Size: N = 433
Setting: Rehabilitation
to community
United States
PEDro: 6/10 C: Usual care
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Table 3 Continuity of care (Continued)
Trexler 2010 Patients
with ABI
I: Allocated to ‘resource facilitators’
who contacted participants every
2 weeks (via telephone or
home/community visits). A large
focus of the facilitator was
returning the patient to work (CM)
Participation, self reported
health
Levels of participation improved
more in the intervention group
(F= 9.11) and more of the
intervention group were
employed at the time of 6 month
follow up (n = 7 vs n = 4).
Design: RCT
Size: N = 22
Setting: Community
United States
PEDro: 4/10 C: Usual care (no ‘resource
facilitator’
Early supported discharge
Fearon 2012 Patients with
acute stroke
I: Early supported discharge Death or long term
dependency, length of stay,
ADL function, subjective
health status, mood, carer
outcome, patient and carer
satisfaction
Appropriately resourced Early
Supported Discharge models
can reduce length of stay
(equivalent to approximately
7 days). Patients receiving ESD
are more likely to be independent
and living at home OR 0.80
(95% CI 0.67 to 0.97)
Design: SR C: Other models of care
Size: 14 studies
Setting: Acute stroke to home
AMSTAR: 9/11
Short term package
Andersen 2000 Patients
with stroke
Ia: Three home visits from a
geriatric rehabilitation physician
for medication review,
referral/liason with other
services, information
Function, ADLs, mortality,
institutionalisation and
readmission
Significantly less hospital
readmissions in both intervention
groups compared to the control
group at 6 months (26% vs 34%
and 44%).
There was no difference in
functional outcome between
groups at 6 months.
Design: RCT (three arms)
Size: N = 155
Setting: Rehabilitation
to community
Ib: Home visits (average of 3)
from the hospital physiotherapists
for instruction and education
Denmark
PEDro: 7/10 C: Standard aftercare (may have
included outpatient rehabilitation
and home care)
Forster 2009 Patients with
stroke
I: Follow up assessment from a
stroke nurse 5–6 months after
stroke. Issues identified in the
assessment were managed in a
standardised manner
Function, mood, satisfaction
with care, caregiver burden
There were no real differences
between groups at 12 month
follow up however patients
reported improved satisfaction
with care in some areas.
Design: RCT
Size: N = 265
Setting:
Community
United Kingdom C: Letter sent to GP recommending
6 month review
PEDro: 8/10
Ghaffar 2006 Patients with
mild TBI
I: Patients were followed up in a
multidisciplinary TBI clinic within
1 week of injury and offered
pharmacotherapy, PT, OT and
supportive psychotherapy if
required
Symptoms, General Health
questionnaire, cognition
In general there were no
significant differences between
group however a small subgroup
(those with a premorbid
psychiatric history) appeared
to benefit from treatment,
reporting lower levels of
depression at 6 months (F= 6.8).
Design: RCT
Size: N = 191
Setting: ED to community
Canada
PEDro: 5/10 C: Usual care (no follow up
arranged)
Wade 1997 Patients with
head injury
I: Routine follow up from an
occupational therapist or
psychologist 7–10 days post
injury with organisation of
further follow up as required
Symptoms As a whole, there were no
significant differences between
groups however subgroup
analyses revealed that patients
in the control group with a
more severe head injury were
more likely to have continuing
problems at 6 months.
Design: RCT
Size: N = 1156
Setting: ED to community
C: Usual care (no routine followup)
United Kingdom
PEDro: 3/10
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Table 3 Continuity of care (Continued)
Wade 1998 Patients with
head injury
I: Routine follow up from an
occupational therapist or
psychologist 7–10 days post
injury with organisation of
further follow up as required
Symptoms The intervention group reported
fewer or less severe concussion
symptoms and less disruption of
social activities at 6 months than
the control group.
Design: RCT
Size: N = 314
Setting: ED, hospital and
community C: Usual care (no routine followup)
United Kingdom
PEDro: 5/10
Ytterberg 2000 Patients with
stroke
I: All day follow up visit one
month after discharge
Self reported health status There were no significant
differences between groups
Design: RCT
C: Usual care with no specific
follow-up arrangedSize: N = 111
Setting: Community
Sweden
PEDro: 2/10
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[23]. In contrast, the SR involving people with TBI
[25] was published in 1999 and addressed few of the
AMSTAR criteria (3/11). Their review comprised three
low quality studies, one of which was randomised. The
RCT conducted with stroke survivors was of high quality
(PEDro 8/10). The three RCTs conducted with people
with a TBI were of good quality (PEDro ≥6/10) whereas
the RCT conducted with people with an ABI was of
poorer quality (PEDro 4/10) and involved a small num-
ber of participants (n = 22).
Effects of interventions
Patient outcomes The SR conducted with stroke survi-
vors found that there were no differences between
groups on mortality at follow up [23]. Both SRs [23,25]
and two of the RCTs [26,28] reported on levels of de-
pendence in ADL function post intervention. Both SRs
found that there were no significant differences between
groups. However, Ellis and colleagues found in a sub-
group analysis that stroke survivors with mild to moder-
ate disability (Barthel score of 15 to 19) who received
case management were more likely to be have a signifi-
cant reduction in dependence (OR 0.62, 95% CI 0.44
to 0.87) in comparison to those who did not receive case
management. One RCT conducted with people with TBI
found that patients receiving case management had
improved functional status (on a composite outcome
measure) at follow up however the magnitude of the ef-
fect was unclear [28], whereas another RCT involving
people with TBI found there were no significant differ-
ences between groups in ADL function measured using
the Functional Independence Measure and Disability
Rating Scale at follow-up [26]. Both SRs and four of the
RCTs reported on levels of participation at follow up.
The SR involving stroke survivors found that there wereno significant differences between groups at follow up.
The SR involving people with a TBI reported that there
was some evidence (based on two NRCTs) that case
management improved vocational status. The three
RCTs conducted with people with TBI showed conflict-
ing results; two of the RCTs were unable to find differ-
ences between groups in participation outcomes [26,28]
whereas the other RCT found that people in the inter-
vention group reported less impact on work and leisure
roles than those in the control group at follow up [27].
The RCT involving people with an ABI provided a case
management intervention focussed on returning people
to work and found that at six month follow up a higher
number of people from the intervention group were
employed (64% vs 36%) [29]. One SR [23] and five RCTs
[24,26-29] examined the effects of case management
intervention on quality of life. The SR and four of the
RCTs found there were no differences in outcomes be-
tween groups [23,24,26,27,29]. The remaining study found
that the intervention group had significantly better ad-
justed mean scores on the Euroqol (0.78 vs 0.67) [28].
Secondary outcomes The SR involving stroke survivors
reported on participant satisfaction [23]; they found evi-
dence (based on three RCTs included in their review)
suggesting that participants receiving case management
were more satisfied that someone had listened to them
(OR 1.58, 95% CI 1.14 to 2.19).
In summary, one systematic review containing 16
RCTs and one RCT published since the review suggest
that there are few overall significant benefits in provid-
ing case management services for people with stroke
however there may be some benefits in providing case
management for people with mild to moderate levels of
disability. In addition, case management may increase
satisfaction with care. One systematic review and four
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fectiveness of case management for people with TBI.
Continuity of care - Early supported discharge (ESD)
Description of reviews and studies We identified a
Cochrane review published in 2012 that examined the
effect of early supported discharge programs after stroke
[30]. Early supported discharge was defined in the review
as “any intervention that aimed to accelerate discharge
from hospital with the provision of support (with or
without a 'therapeutic' rehabilitation intervention) in a
community setting”. The review included 14 RCTs. No
RCT, NRCT, CBA or ITS studies were identified which
were published subsequently to this review and addressed
this research question.
Quality of reviews and studies
The review was well reported, addressing 9 out of 11 of
the AMSTAR criteria.
Effects of interventions
Patient outcomes The SR reported on level of depend-
ence in ADL and found that based on the results of nine
trials there were no significant differences between
groups. However, the SR found that patients receiving
an ESD program were marginally more independent in
extended ADL (standardised mean difference (SMD)
0.12 (95% CI 0.00 to 0.25)). The SR found no signifi-
cant effect on quality of life or mortality. However, when
assessing the outcome of death or dependency they
found strong evidence that ESD programs led to similar
or improved functional outcome (OR 0.80 (95% CI 0.67
to 0.97)) [30]. Subgroup analysis showed that patients
with mild to moderate levels of disability (initial Barthel
index >9/20) appeared to benefit most from ESD inter-
vention however, it should be noted that the benefits as-
sociated with ESD were not always sustained at longer
term follow up assessment [30].
Secondary outcomes The SR reported on the effect on
length of stay and found ESD intervention was associ-
ated with a significant reduction in length of stay in acute
care equivalent to approx seven days (Mean Difference
(MD) -6.84 (95% CI −11.20 to −2.49)). Overall patients
receiving ESD services were significantly more likely to re-
port satisfaction with care services (OR 1.60, 95% CI 1.08
to 2.38, P = 0.02).
In summary, there is Level I evidence that ESD pro-
grams can improve functional outcomes, reduce length
of stay and increase patient satisfaction. The authors of
the review reached a consensus that the important fac-
tors of the ESD service included delivery of therapy in
the home setting and coordinated multidisciplinary care.
The greatest benefits were seen where the ESD teamcoordinated the hospital discharge, post-discharge care
and delivery of home rehabilitation and support.
Continuity of care - Short term programs
Description of reviews and studies We identified six
RCTs in this category [31-36]; three of these studies
involved people with a traumatic brain injury and the
remaining involved people with stroke. No SRs, NRCT,
CBA or ITS studies were identified which addressed this
research question. The purpose of the intervention, and
health professionals delivering the intervention in this cat-
egory varied greatly. Study interventions included: visits
from a geriatric rehabilitation physician or physiotherapist
[31], assessment conducted by a stroke nurse six months
after stroke [32], follow up in a multidisciplinary TBI clinic
[33], routine follow up approximately one week post TBI
from an occupational therapist or psychologist [34,35] and
follow up one month following discharge after stroke [36].
Quality of reviews and studies
As seen in Table 3, PEDro scores for included studies
tended to be low and scores ranged from 2/10 to 8/10.
Effects of interventions
Patient outcomes There were few significant findings in
favour of short term programs of continuity of care. One
RCT reported on mortality outcomes and found no signifi-
cant differences between groups [31]. Two RCTs reported
on level of dependence in ADL and found no significant
differences between groups [31,32]. Five RCTs reported on
participation outcomes; three of these found no significant
differences between groups [31-33]. The remaining two
RCTs were conducted with people with TBI and found that
people in the control group were significantly more likely
to have difficulties in participation (as measured by the
Rivermead Head Injury follow up Questionnaire) than
those in the intervention group [34,35]. Two RCTs exam-
ined effects on quality of life and were unable to identify
significant benefits associated with intervention [33,36].
Secondary outcomes One of the RCTs assessed partici-
pant satisfaction and found that patients receiving the
intervention reported that they were more satisfied with
the information provided to them and the planning prior
to their return home compared with usual care [31].
In summary, we identified a number of studies evalu-
ating short term programs however, low study quality
and clinical heterogeneity means that it is difficult to
draw conclusions about these studies.
Quality monitoring
Description of reviews and studies
We included one SR [37], five RCTs [20,38-41] and one
NRCT [42] that addressed this question (See Table 4).
Table 4 Quality monitoring
Study Patient Intervention/Comparator Outcomes Results
Parker 2012 Patients
with stroke
I: Studies that evaluated the relationship
between compliance with≥ 2 quality
metrics and patient centered outcomes
or the public reporting of stroke metrics
and QI activity, quality of care and
patient centered outcomes.
Mortality, ADL function,
adverse events/complications,
QOL, patient satisfaction
There is some evidence of positive
associations between stroke metric
compliance and improved
outcomes however, there are few
high quality studies. Information
on the impact of public reporting
of stroke quality metric data is
extremely limited
Design: SR
Size: 16 studies
Setting: Acute All levels
of severity
AMSTAR: 3/11
Dirks 2012 Patients
with stroke
I: An intervention based on the
‘Breakthrough Series’ model to increase
the rates of thrombolysis in acute
stroke wards
Treatment rates of tPA, time
from event to admission,
death or disability, QOL
Thrombolysis rates in the
intervention group rose earlier
and remained higher than the
control group.
C: Usual careDesign: cluster RCT
Size: N = 5515 patients
from 12 hospitals
Setting: Acute
Netherlands
PEDro: 7/10
Falconer 1993 Patients
with stroke
I: Care was provided based on an
interdisciplinary care model and the
use of a ‘critical path method (CPM)
to plan care and discharge. The CPM
provided the team with information
and continuous feedback
Length of hospital stay,
hospital charges, ADL
function, patient satisfaction
The groups received comparable
type, intensity and duration of
treatment and there was no
significant difference between
groups in length of stay and
hospital charges
Design: RCT
Size: N = 128
Setting: Rehabilitation
United States
PEDro: 4/10 C: Usual care in which the care model
was more multidisciplinary and a
CPM was not used.
Hinchey 2010 Patients
with stroke
I: Multifaceted intervention targeted
towards improving key performance
measures: door-to-needle time for
TPA, dysphagia screening, DVT
prophylaxis and warfarin treatment
for AF. The intervention included
meetings, identification of barriers,
reminder systems, education, audit
and feedback.
Difference in post-intervention
adherence rates
The intervention group had a
significantly higher rate of patients
with AF discharged on warfarin
however there were no other
significant differences between
groups.
Design: Controlled trial
Size: N = 2071
pre-intervention patients
and 1240 post-intervention
patients
Setting: Acute
United States C: Audit and feedback alone
D & B: 13/26
Johnston 2010 Patients
with stroke
I: Standardised stroke discharge orders
on adherence to 3 practices:
normalisation of blood pressure, statin
treatment and anticoagulation for AF
Management of these
outcomes at 6 months
There was no significant impact of
intervention at the hospital level.
Design: cluster RCT
Size: 12 hospitals
(3361 patients)
Analysis at the patient level found
that rates of optimal treatment
increased at intervention hospitals
whereas there was no change at
control hospitals. Improvements
were primarily related to increased
statin use and improved blood
pressure control.
Setting: Acute C: Usual care (no standardised orders)
United States
PEDro: 8/10
Lakshminarayan 2010 Patients
with stroke
I:Intervention to improve care quality
as measured by
Ten performance measures
(eg tPA use, smoking
cessation counselling, PT
and OT evaluation or
treatment <48 hours)
There were no significant
differences between groups
Design: cluster RCT 10 key performance measures.
Intervention included receipt of a
report on baseline quality, the use of
clinical opinion leaders and assistance
from study personnel to implement
changes and overcome barriers
Size: 19 hospitals
(1211 patients)
Setting: Acute
United States
PEDro: 8/10 C: Received report on baseline
quality only
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Table 4 Quality monitoring (Continued)
Strasser 2008 Patients
with stroke
I: Both groups received summaries of
their team’s performance on process
measures. The intervention group
received team training provided over
6 months. Comprised a 2.5 day
workshop for team leaders to develop
team problem-solving strategies,
written action plans to address team
process problems and support to
implement action plans
ADL function, community
discharge and length of stay
Patients in the intervention group
improved significantly more on
the FIM motor score than the
control group (13.6% absolute
difference in percentage of
patients gaining more than
23 points)
Design: cluster RCT
Size: N = 487 patients
Setting: Rehabilitation
United States
PEDro: 5/10
C; Received the summary of
performance only
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this research question. The SR conducted by Parker and
colleagues (2012) examined one aspect of quality moni-
toring; that is whether the evaluation of compliance
with quality metrics or public reporting improved pa-
tient outcomes including mortality, disability, quality of
life or patient satisfaction. They included 14 observa-
tional studies that examined compliance with quality
metrics and two observational studies that examined
public reporting; all studies took place in acute stroke
settings. Four of the primary studies (3 RCTs, 1 NRCT)
included in our review aimed to improve compliance
with interventions regarded as best practice in acute care
(for example, increasing the rates of thrombolysis to ap-
propriate patients) [38-40,42]. The quality monitoring
intervention approaches used within these studies varied
(Table 4). Two RCTs examined quality monitoring inter-
ventions in a stroke rehabilitation setting [20,41]. The
processes involved in the interventions were different
however, the aim of both interventions was to improve
team functioning and involved strategies such as audit,
feedback and team training
Quality of reviews and studies
The SR addressed 3 of the 11 AMSTAR criteria. The
RCTs ranged in quality; two were of lower quality
with PEDro scores of 4/10 [20] and 5/10 [41]. The
remaining three RCTs were of good quality (≥6/10
on the PEDro scale) [38-40]. The NRCT scored 13/26 on
the Downs and Black Scale reflecting methodological
weaknesses [42].
Effects of interventions
Patient outcomes The SR reported broadly on the ef-
fect on patient outcomes (which included mortality,
disability, quality of life and patient satisfaction). They
found conflicting evidence as approximately half of the six-
teen studies included in the review found mostly positive
relationships with patient outcome whereas the other half
reported either limited or no significant relationship [37].One good quality RCT reported on mortality following
intervention and found no significant differences between
groups [38]. Three RCTs reported on participants’ level of
dependence in ADLs post intervention [20,38,41]. Findings
were mixed; one of the RCTs found no significant differ-
ence [20] whereas another reported that patients in the
intervention group made more improvement on the motor
component of the Functional Independence Measure
(13.6% absolute difference in percentage of patients gaining
more than 23 points) [41]. In contrast, Dirks and col-
leagues found that although the quality monitoring inter-
vention achieved their goal of increasing thrombolysis
rates, patients in the intervention group were less likely to
have a good clinical outcome (Modified Rankin Scale <3)
at 3 months (adjusted OR, 0.56 (95% CI 0.42 to 0.74) [38].
This same RCT found there were no significant differences
between groups in quality of life [37].Secondary outcomes Three RCTs reported on resource
use. One RCT found that there were some cost savings
associated with the intervention due to lower hospital
admission costs (difference -455 USD; 95% CI -232
to -679 USD) [38]. However, two RCTs conducted in stroke
rehabilitation settings found no significant differences
between groups in length of stay [20,41]. Three RCTs
[38-40] and one NRCT [42] reported on the effect of the
quality monitoring intervention on process measures. The
study conducted by Dirks and colleagues found that rates
of thrombolysis were increased in the intervention group
(44.3% vs 39.8% in the control group (difference 4.5%;
95% CI 3.1% to 5.9%) [38]. Johnston and colleagues found
that standardised stroke discharge orders increased the
rates of ‘optimal treatment’ in individual patients (from
37% to 45%) [39] and Hinchey and colleagues found
significant improvements in achieving one of four
targeted process outcomes (98% in the intervention
group compared to 87% in the control group) which
was discharging a patient with atrial fibrillation on
warfarin. Only one of the studies was unable to find any
significant benefits in favour of the intervention group on
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satisfaction and found that patients in the intervention
group reported significantly lower levels of satisfaction
with intervention (mean 7.7 vs 8.8) [20].
In summary, level I evidence from one systematic re-
view and six clinical trials indicates that while some im-
provements in processes outcomes have been associated
with quality monitoring interventions, the effects on pa-
tient and health system outcomes are not consistent.
There is not clear evidence supporting a particular ap-
proach to quality monitoring, and the primary studies
evaluating these interventions were of variable methodo-
logical quality.
Discussion
This review addressed six research questions; we found
eligible papers to address four of these six questions. We
included five systematic reviews and 21 trials (20 of
which were randomised) in this review to answer these
four questions. The majority of studies involved people
with stroke rather than TBI, and most of the studies in-
volved participants with mild to moderate levels of dis-
ability rather than people with a severe ABI. The RCTs
were of mixed quality; most (n = 13, 65%) were assessed
as being good quality with a PEDro score of ≥6/10.
Overall we found some evidence from three RCTs sup-
porting integrated care models, and strong evidence
from one systematic review for the use of early sup-
ported discharge teams after stroke. We found there was
little evidence (based on one systematic review and one
RCT) to support case management services for people
with stroke and there was insufficient evidence from
which to draw conclusions regarding case manage-
ment for people with TBI (based on one systematic
review and four RCTs). There was little evidence
from one systematic review and one RCT to support
the use of integrated care pathways and while some
quality monitoring interventions have lead to im-
provements in patient care, results are inconsistent and
there is insufficient evidence to support one particular
quality monitoring approach (based on one systematic
review and six clinical trials).
This review is the first known review of its type in
ABI and provides useful information for health care ser-
vice providers, funding bodies or policy makers wishing
to establish or modify existing services for people with
an ABI. This review complements the ABIEBR [9] mod-
ule on models of care by including studies involving
people with stroke and thus synthesising a larger body of
literature.
The interventions of interest within this review
were complex interventions; this presents issues in
interpretation of the research. For example, the stud-
ies examining the effect of integrated care compareddifferent interventions in which the degree of integration
was only one of the possible explanatory variables. The
study conducted by Kalra and colleagues compared com-
prehensive stroke care provided in a discrete location
with care provided by a mobile stroke team [16]. It is
possible that benefits in the comprehensive care group
were related to other factors such as the dedicated nurs-
ing staff on the comprehensive unit.
Our finding regarding the lack of evidence for inte-
grated care pathways warrants further discussion. The
systematic review by Kwan and colleagues was published
in 2002 and only identified three RCTs. The RCTs failed
to identify any significant benefits following the intro-
duction of ICPs and suggest that a “one size fits all”
approach does not work. However, two of these RCTs
[20,43] were poorly reported and published in the early
1990s and as such, findings from these studies may be of
limited relevance to current clinical practice. The more
recent RCT conducted by Middleton and colleagues [18]
was of high quality and much more specific in nature
than the ICPs included within the 2002 systematic re-
view. This type of pathway may be more effective and
further high quality research is warranted to determine
the effect of similar pathways for other impairments
following ABI.
Evaluation of quality monitoring interventions is chal-
lenging in that the different quality monitoring interven-
tions may vary in their effectiveness and their effectiveness
may in turn vary in different contexts and settings. The
baseline performance of the multidisciplinary team, recep-
tiveness to intervention and the drivers of change in each
setting may also influence the outcome, and should thus
be reported in any trial. It is possible that clinicians may
respond more positively to feedback regarding individual
performance outcomes than team outcomes; this was
also not addressed in any of the included studies. The
majority of reviews and studies included within this re-
view relate to people with mild to moderate levels of
disability in terms of their level of independence in activ-
ities of daily living. The focus on people with less severe
disability may partly relate to the nature of the research
questions. Case management or follow up programs tend
to be directed at people returning to their own home
who are less severely disabled than those discharged to
residential care services. This may also be due to the
presence of less research related to people with higher
levels of disability who may be excluded from studies
due to communication or cognitive impairment. How-
ever, long term care for people with severe levels of dis-
ability is costly and people with severe levels of disability
may gain more from interventions directed at improving
their quality of life. More research is required to evaluate
the best methods of organising health care services for
this group. Most of the included studies also recruited
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previously described, in most settings worldwide people
with an ABI tend to be treated by the same team in the
same settings; therefore researchers should consider a
pragmatic approach by including all patients with ABI.
While the needs and goals of people with different diag-
noses may vary, there are areas of commonalities and
the needs of all people with an ABI should be consid-
ered in the establishment of services.
There are some limitations associated with this review.
Firstly, although we included research designs of the
highest quality, the way in which some studies were re-
ported suggests that they were susceptible to bias and
therefore results should be interpreted with caution. All
studies were appraised and results of the appraisal were
presented in Tables 1, 2, 3 and 4. In addition, studies of
particularly high or low quality were noted in the text.
Our search for eligible studies was highly sensitive yield-
ing a large volume of titles and abstracts; however it is
possible that publication bias is present as we excluded
conference proceedings and did not search clinical trial
registries or contact authors. Furthermore, one author
(KL) screened titles and abstracts identified from the
search and one person (KL) extracted data (checked by a
second author (LP)). We also did not include studies
published prior to 1980 and those published in lan-
guages other than English.
We summarised the evidence using the same classifi-
cation system as the ABIEBR to ensure consistency how-
ever, this was at the expense of using other more highly
regarded systems such as GRADE [44]. There are many
factors involved in designing or reviewing health care
services. This review addresses specific organisational in-
terventions but does not address issues such as the level
of staffing and personnel that should be involved in pro-
viding care.
Conclusions
Based on the evidence identified in the review we identi-
fied several implications for the establishment or review
of the organisation of health care services for people
with ABI. We have also identified areas in which there is
conflicting evidence and where more evidence is re-
quired. Our findings suggest: there is Level I evidence
that improved outcomes, including a shorter length of
stay, are possible under an integrated care model where
acute, rehabilitation, and community/ambulatory ser-
vices are provided under one management team; there is
Level I evidence that compliance with a specific inte-
grated care pathway in the acute setting may result in
improved patient outcomes and reduced mortality in
stroke patients; case management after inpatient re-
habilitation for stroke patients is associated with few
reported benefits for stroke survivors; case managementfor patients with TBI has not yet been well studied; and
there is conflicting evidence that quality monitoring inter-
ventions may lead to improved patient outcomes however
at present, no particular quality monitoring approach can
be recommended.
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